Gelteq Ltd (GELS) income statement
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27+0.00 (+0.37%)
Close on Nov 18, 2026Market cap $2.89MP/E –Yield –
Gelteq Ltd income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 30.3%
- Operating margin
- -3317.7%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 0.09
- Debt to equity
- –
- Debt to assets
- 25.4%
- Cash to current liabilities
- 0.2%
Valuation
- P/E ratio
- –
- Price to sales
- 25.77
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?